Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.03 million. The enterprise value is $234,295.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 2.13 million shares outstanding. The number of shares has increased by 213.06% in one year.
| Current Share Class | 2.13M |
| Shares Outstanding | 2.13M |
| Shares Change (YoY) | +213.06% |
| Shares Change (QoQ) | +27.58% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 7.13% |
| Float | 2.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -660.37% and return on invested capital (ROIC) is -418.88%.
| Return on Equity (ROE) | -660.37% |
| Return on Assets (ROA) | -130.88% |
| Return on Invested Capital (ROIC) | -418.88% |
| Return on Capital Employed (ROCE) | 624.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.55M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.81% in the last 52 weeks. The beta is 0.45, so SLRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -77.81% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 38.29 |
| Average Volume (20 Days) | 6,254,997 |
Short Selling Information
The latest short interest is 803,608, so 37.78% of the outstanding shares have been sold short.
| Short Interest | 803,608 |
| Short Previous Month | 678,491 |
| Short % of Shares Out | 37.78% |
| Short % of Float | 37.97% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.18M |
| Pretax Income | -6.46M |
| Net Income | -5.10M |
| EBITDA | -5.18M |
| EBIT | -5.18M |
| Earnings Per Share (EPS) | -$3.13 |
Full Income StatementBalance Sheet
The company has $794,886 in cash and n/a in debt, giving a net cash position of $794,886 or $0.37 per share.
| Cash & Cash Equivalents | 794,886 |
| Total Debt | n/a |
| Net Cash | 794,886 |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | -829,724 |
| Book Value Per Share | -0.39 |
| Working Capital | -862,924 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.14M |
| FCF Per Share | -$1.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |